Viewing Study NCT02812667


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-01-07 @ 11:47 PM
Study NCT ID: NCT02812667
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2016-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Lyudmila Bazhenova, M.D.
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 160186
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View